Beach Boys’ Brian Wilson, 81, ‘suffering from dementia’ as touring company seeks to place him under a conservatorship… weeks after the singer’s wife Melinda died
- Wilson’s tour group said he has a “major neurocognitive disorder.”
- The company has filed for receivership to ensure he is treated appropriately
- Wilson has a decades-long history of mental health and substance abuse issues
Legendary Beach Boys mastermind and singer Brian Wilson is reportedly suffering from dementia.
A representative of the touring company representing the 81-year-old artist, one of the most acclaimed songwriters of the 20th century, said in a lawsuit that Wilson suffers from a “severe neurocognitive disorder (such as dementia). ‘ according to documents obtained on Thursday by The explosion.
In the filing, the hitmaker’s team requests a conservatorship for the legendary musician to help treat the alleged condition.
News of Wilson’s condition comes after he suffered a tragedy late last month when his longtime wife Melinda died at the age of 77.
The musician has a decades-long history of mental health issues and has struggled with substance abuse in the past, which the tour company cites as reasons why he may reportedly be unable to care for himself as his condition worsens.
A lawsuit from the touring company for Beach Boys mastermind Brian Wilson, 81, said in the lawsuits that he suffers from dementia, according to documents obtained by The Blast; seen in 2020 in Santa Rosa Beach, Florida
Wilson (far right) is considered one of the greatest songwriters of the 20th century for his innovative work with The Beach Boys (pictured in 1964). In addition to composing many of their tunes, he sang lead and background vocals and played multiple instruments on their records; (L – R) Carl Wilson, Dennis Wilson, Mike Love, Al Jardine and Brian Wilson
Wilson’s travel company says in its filing that he is currently being treated for dementia.
“The (proposed) conservator does NOT have the capacity to provide informed consent for the administration of medications appropriate for the care and treatment of severe neurocognitive disorders (including dementia),” it claims.
“The assessed deficits in mental functioning … significantly impair the ability of the (proposed) conservator to understand and appreciate the consequences of consenting to the administration of medications for the care and treatment of serious neurocognitive disorders,” it added company to it.